Page results
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
-
This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
This page is for cancer patients receiving immunotherapy treatment.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
UCLH consultant neurologist Dr Catherine Mummery has been announced as the new Chair of the NIHR Dementia Translational Research Collaboration.
-
A new study at UCLH and UCL aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.
-
This information is for patients having gynaecology surgery who may also need bowel (colorectal) surgery as part of their cancer treatment.
File results
-
FOI/2023/0199 - Patients diagnosed with Cauda Equina Syndrome
-
FOI/2023/0201 - Gas and air suspension in maternity unit
-
FOI/2023/0206 - Service and maintenance contracts for digital/ smart buildings platform, fire alarms, security/ CCTV
-
FOI/2023/0208 - Patient trolleys/ stretchers
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0214 - Patients waiting over 78 weeks for elective care
-
FOI/2023/0215 - British sign language procurement and communications
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0262 - Clinical trial participation